Summary slide.png (125.13 kB)

Outcomes in GLP-1 RA-Experienced Patients Switching to Once-Weekly Semaglutide in a Real-World Setting: The Retrospective, Observational EXPERT Study

media

posted on 2021-02-04, 16:03 authored by Ildiko Lingvay, Andreas R. Kirk, Søren Lophaven, Michael L. Wolden, Jay H. Shubrook

Article full text

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

References

https://link.springer.com/article/10.1007/s13300-021-01010-4

Usage metrics

Read the peer-reviewed publication

Outcomes in GLP-1 RA-Experienced Patients Switching to Once-Weekly Semaglutide in a Real-World Setting: The Retrospective, Observational EXPERT Study

Diabetes Therapy

Keywords

Database research GLP-1 receptor agonists Glycaemic control Observational study Type 2 diabetes Weight loss

Licence

CC BY-NC 4.0

Outcomes in GLP-1 RA-Experienced Patients Switching to Once-Weekly Semaglutide in a Real-World Setting: The Retrospective, Observational EXPERT Study

History

References

Usage metrics

Read the peer-reviewed publication

Categories

Keywords

Licence

Exports